Statement on Use of DNA Testing for Presymptomatic Identification of Cancer Risk

Francis S. Collins, Lennette J. Benjamin, David Botstein, Jerome R. Cox, Norman Davidson, Joe W. Gray, David E. Housman, Neil Holtzman, Kay R. Jamison, Rodney Rothstein, Diane C. Smith, Lloyd M. Smith, M. Anne Spence, Shirley M. Tilghman

Research output: Contribution to journalArticle

130 Scopus citations
Original languageEnglish (US)
Number of pages1
JournalJAMA: The Journal of the American Medical Association
Volume271
Issue number10
DOIs
StatePublished - Mar 9 1994

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Collins, F. S., Benjamin, L. J., Botstein, D., Cox, J. R., Davidson, N., Gray, J. W., Housman, D. E., Holtzman, N., Jamison, K. R., Rothstein, R., Smith, D. C., Smith, L. M., Spence, M. A., & Tilghman, S. M. (1994). Statement on Use of DNA Testing for Presymptomatic Identification of Cancer Risk. JAMA: The Journal of the American Medical Association, 271(10). https://doi.org/10.1001/jama.1994.03510340075038